Beijing Biostar Pharmaceuticals Co., Ltd. (HKG:2563)
Hong Kong · Delayed Price · Currency is HKD 3.650
+0.020 (0.55%)
Aug 27, 2026, 2:47 PM HKT
HKG:2563 Market Cap
HKG:2563 has a market cap or net worth of 1.32 billion as of August 27, 2026. Its market cap has decreased by -60.07% in one year.
Market Cap
1.32B
Enterprise Value
781.99M
Revenue
63.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.65
ChartMarket Cap Chart
Since October 31, 2024, HKG:2563's market cap has decreased from 7.58B to 1.32B, a decrease of -82.55%. That is a compound annual growth rate of -61.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 1.32B | -25.77% |
| Dec 31, 2025 | 1.78B | -75.18% |
| Dec 31, 2024 | 7.18B | -5.29% |
| Oct 31, 2024 | 7.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AIM Vaccine | 1.98B |
| Guangzhou Innogen Pharmaceutical Group | 1.84B |
| HighTide Therapeutics | 1.83B |
| Mabpharm | 1.77B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.60B |
| SinoMab BioScience | 1.54B |
| Zhaoke Ophthalmology | 1.37B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.26B |